Back to results
US 9,802,949 B2Granted
Fused ring compounds as hepatitis C virus inhibitors, pharmaceutical compositions and uses thereof
AssigneeSunshine Lake Pharma Co., Ltd.
InventorsYingjun Zhang, Jiancun Zhang, Hongming Xie, Qingyun Ren, Shifeng Li, Changping Fu, Bailin Hu, Xiwei Wu, Changhua Tang
Life of this patent
Estimating the term…
Abstract
Provided are fused tricyclic compounds effective to inhibit the function of the NS5A protein of formula (I), wherein X, X′, Y, Y′, A, A′, Q1, Q2, R1-R4, X4, R5a, f and W are defined as in the description. Also provided herein are pharmaceutical compositions thereof, and uses in the manufacture of a medicament for treating HCV infection or a HCV disorder thereof.
Claims4
A Compound having one of the following structures:
- or a stereoisomer, a geometric isomer, a tautomer, an N-oxide, a hydrate, or a pharmaceutically acceptable salt thereof.
Dependencies are inferred from the claim text.